| Original language | English |
|---|---|
| Pages (from-to) | 664-665 |
| Number of pages | 2 |
| Journal | Clinical and Experimental Rheumatology |
| Volume | 40 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2022 |
| Externally published | Yes |
Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
Z. Layegh*, F. Hooijberg, C. Bastida, A. D.R. Huitema, T. Rispens, C. G. Wolbink
*Corresponding author for this work
Research output: Contribution to journal › Letter › Academic › peer-review